News

Oligonucleotides are short, single or double-stranded fragments of DNA or RNA that can be used for therapeutic purposes. Originally, there was an emphasis on using this new drug modality for treating rare diseases, yet they have also shown great...

Researchers at UCSF have developed a novel, potentially life-saving technique that may prevent antibodies from prompting the immune system to reject specifically tailored therapeutic and transplant cells. It has been particularly difficult to cure rejection caused by antibodies as opposed...

Due to the fact that many contract manufacturing organisations (CMOs) are the only facilities able to produce vaccines and treatments in the enormous volumes required, outsourcing has become an essential component of the biopharmaceutical business. Other justifications for outsourcing...

Flu is a virus, so it can make you feel miserable. You might also feel tired and have a cough or fever. The flu can be dangerous if your body can't fight it off. This can happen if you're...

Polarean Imaging plc, the medical imaging technology company, announces that the US Food and Drug Administration (FDA) has granted approval for its drug device combination product, Xenoview. Xenoview, prepared from the Xenon Xe 129 Gas Blend, is a hyperpolarized contrast...

PeptiDream Inc., a Japan-based biopharmaceutical company, has entered a new multi-target collaboration and license agreement with Merck & Co, Inc. (known as MSD outside the U.S.) focused on the discovery and development of novel peptide drug conjugates (PDCs). PeptiDream will...

Everest Medicines, a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, began the first phase of operations at its global manufacturing site dedicated to mRNA vaccine production in Jiashan, Zhejiang Province. The first phase...